Hims & Hers is set to report second-quarter 2026 results on August 10, with executives likely addressing the newly launched Hers app featuring doctor-led, AI-native care capabilities announced just days earlier. This technology rollout positions the platform against traditional telehealth competitors by emphasizing machine learning-driven personalization in weight management and wellness offerings. Traders are also watching commentary on the shift toward branded GLP-1 medications amid ongoing regulatory scrutiny of compounded versions, alongside metrics on user growth and adjusted EBITDA. The call will clarify whether the AI enhancements are driving measurable adoption or if broader platform dynamics remain the dominant factor.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoWhat will Hims say during their next earnings call?
What will Hims say during their next earnings call?
NUOVO
10 ago 2026
Quarter 20+ times
95%
Subscriber 15+ times
78%
Platform 10+ times
96%
Fiscal 10+ times
9%
Peptide 5+ times
61%
GLP-1
77%
Testosterone
75%
Eucalyptus
90%
Longevity
80%
Wearable
73%
Europe
60%
Amazon
26%
Regulation
26%
-No Qualifying Event-
3%
$2,538 Vol.
Quarter 20+ times
$38 Vol.
95%
Subscriber 15+ times
$0 Vol.
78%
Platform 10+ times
$539 Vol.
96%
Fiscal 10+ times
$518 Vol.
9%
Peptide 5+ times
$0 Vol.
61%
GLP-1
$85 Vol.
77%
Testosterone
$63 Vol.
75%
Eucalyptus
$116 Vol.
90%
Longevity
$0 Vol.
80%
Wearable
$71 Vol.
73%
Europe
$61 Vol.
60%
Amazon
$0 Vol.
26%
Regulation
$0 Vol.
26%
-No Qualifying Event-
$1,047 Vol.
3%
This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdfHims & Hers is set to report second-quarter 2026 results on August 10, with executives likely addressing the newly launched Hers app featuring doctor-led, AI-native care capabilities announced just days earlier. This technology rollout positions the platform against traditional telehealth competitors by emphasizing machine learning-driven personalization in weight management and wellness offerings. Traders are also watching commentary on the shift toward branded GLP-1 medications amid ongoing regulatory scrutiny of compounded versions, alongside metrics on user growth and adjusted EBITDA. The call will clarify whether the AI enhancements are driving measurable adoption or if broader platform dynamics remain the dominant factor.
This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
Mercato aperto: Aug 7, 2026, 7:02 PM ET
Volume
$2,538Data di fine
10 ago 2026Mercato aperto
Aug 7, 2026, 7:02 PM ETResolver
0x65070BE91...This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdfHims & Hers is set to report second-quarter 2026 results on August 10, with executives likely addressing the newly launched Hers app featuring doctor-led, AI-native care capabilities announced just days earlier. This technology rollout positions the platform against traditional telehealth competitors by emphasizing machine learning-driven personalization in weight management and wellness offerings. Traders are also watching commentary on the shift toward branded GLP-1 medications amid ongoing regulatory scrutiny of compounded versions, alongside metrics on user growth and adjusted EBITDA. The call will clarify whether the AI enhancements are driving measurable adoption or if broader platform dynamics remain the dominant factor.
This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
Volume
$2,538Data di fine
10 ago 2026Mercato aperto
Aug 7, 2026, 7:02 PM ETResolver
0x65070BE91...Hims & Hers is set to report second-quarter 2026 results on August 10, with executives likely addressing the newly launched Hers app featuring doctor-led, AI-native care capabilities announced just days earlier. This technology rollout positions the platform against traditional telehealth competitors by emphasizing machine learning-driven personalization in weight management and wellness offerings. Traders are also watching commentary on the shift toward branded GLP-1 medications amid ongoing regulatory scrutiny of compounded versions, alongside metrics on user growth and adjusted EBITDA. The call will clarify whether the AI enhancements are driving measurable adoption or if broader platform dynamics remain the dominant factor.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti